Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
07:00am, Monday, 03'rd Nov 2025
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational
Moderna: Focus On Cancer Vaccines, Not Buyout
04:05pm, Friday, 31'st Oct 2025
Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on mRN
Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?
03:57pm, Friday, 31'st Oct 2025
Moderna Inc (NASDAQ:MRNA) shares are trading lower on Friday afternoon, giving back a portion of the gains seen on Thursday. Here's what investors need to know.
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 31'st Oct 2025
Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?
06:01am, Friday, 31'st Oct 2025
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges
05:25pm, Thursday, 30'th Oct 2025
Shares of a social media juggernaut slumped as investors balked at its rapidly accelerating spending on artificial intelligence, while reports of potential partnership or buyout talks helped a vaccine
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
11:06am, Thursday, 30'th Oct 2025
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna (MRNA) Outperforms Broader Market: What You Need to Know
06:45pm, Friday, 24'th Oct 2025
Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.
Moderna Named a Top Employer by Science for Eleventh Consecutive Year
02:42pm, Thursday, 23'rd Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers
Moderna to Host Investor Event - Analyst Day
07:00am, Thursday, 23'rd Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
Moderna ends development of CMV vaccine after trial failure
04:34pm, Wednesday, 22'nd Oct 2025
Moderna said on Wednesday it will discontinue development of its experimental vaccine to prevent cytomegalovirus, a common cause of birth defects, after it failed to meet the main goal of a late-stage
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
04:05pm, Wednesday, 22'nd Oct 2025
Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate an
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
01:10pm, Wednesday, 22'nd Oct 2025
Moderna's shares have been southbound for the past few years due to unimpressive financial results. However, progress with the pipeline could significantly boost the stock over the next five years.
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
05:05am, Tuesday, 21'st Oct 2025
"Buying the dip" can be a double-edged sword for investors. Sometimes they can seize the opportunity by purchasing an oversold stock, but other times, that stock is trending lower for a good reason (a
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
08:00am, Sunday, 19'th Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe
